| Literature DB >> 29316936 |
Maciej J K Simon1,2,3, Henry F H Halm3, Markus Quante4.
Abstract
BACKGROUND: Degenerative adult de novo (DAD) scoliosis appears characteristically in the sixth or seventh decade with symptoms of severe back pain and radiculopathy or spinal claudication. The aim of this study was to enhance the knowledge of perioperative complications and detect possible risk factors in this selective DAD scoliosis surgery.Entities:
Keywords: Correction spondylodesis; Degenerative adult de novo scoliosis; Perioperative complications
Mesh:
Year: 2018 PMID: 29316936 PMCID: PMC5761192 DOI: 10.1186/s12891-017-1925-2
Source DB: PubMed Journal: BMC Musculoskelet Disord ISSN: 1471-2474 Impact factor: 2.362
Fig. 1The flow chart demonstrates patients with deformity surgery (n = 622) from 2007 until 2009 and the exclusion process of any type of scoliosis other than of degenerative adult de novo (DAD) scoliosis (n = 92). An extensive patient history was undertaken. If doubts arose, previous radiographic imaging was examined. Additionally, referral doctor and/or family physician were contacted to exclude other causes for scoliosis. Exclusion occurred when idiopathic (n = 412), neuromuscular (n = 68), congenital (n = 33) or vertebral fractures (n = 17) were answered with a “Yes” or radiographic images showed idiopathic or any scoliosis deformation other than DAD scoliosis
Patient epidemiological data, medical disorders and treatments
| 1 | 2 | 3 | 4 | 5 | 6 | 7 | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total | Early complications | Late complications | No complications |
|
|
| ||||||
|
| % |
| % |
| % |
| % | |||||
| Age (years) | 67.2 ± 7.9 | 69.1 ± 8.3 | 67.2 ± 7.4 | 65.3 ± 8.5 | 0.34 | 0.14 | 0.35 | |||||
| BMI (kg/m^2) | 26.6 ± 3.4 | 27.0 ± 3.2 | 26.8 ± 3.2 | 25.9 ± 4.1 | 0.90 | 0.38 | 0.33 | |||||
| Gender | Male | 28 | 30.4 | 7 | 30.4 | 13 | 26.5 | 8 | 40.0 | 0.73 | 0.52 | 0.28 |
| Female | 64 | 69.6 | 16 | 69.5 | 36 | 73.5 | 12 | 60.0 | 0.73 | 0.52 | 0.28 | |
| ASA class | 1 | 1 | 1.0 | 0 | 0.0 | 0 | 0.0 | 1 | 5.0 | – | 0.29 | 0.12 |
| 2 | 62 | 67.3 | 13 | 56.5 | 35 | 71.4 | 14 | 70.0 | 0.22 | 0.37 | 0.91 | |
| 3 | 29 | 31.5 | 10 | 43.4 | 14 | 28.5 | 5 | 25.0 | 0.22 | 0.21 | 0.77 | |
| 4 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | – | – | – | |
| Obesity | 20 | 21.7 | 4 | 17.3 | 11 | 22.4 | 5 | 25.0 | 0.63 | 0.55 | 0.82 | |
| Smoker | 26 | 31.7 | 6 | 30.0 | 12 | 28.5 | 8 | 40.0 | 0.91 | 0.52 | 0.38 | |
| Type 1 Diabetes | 8 | 8.9 | 4 | 8.6 | 4 | 8.6 | 0 | 0.0 | 0.29 | 0.05 | 0.18 | |
| Type 2 Diabetes | 11 | 11.5 | 5 | 12.7 | 6 | 12.7 | 0 | 0.0 | 0.26 | < 0.05 | 0.10 | |
| COPD | 15 | 16.4 | 6 | 26.0 | 7 | 14.5 | 2 | 10.0 | 0.25 | 0.18 | 0.62 | |
| Osteoporosis | 23 | 25.0 | 6 | 26.0 | 14 | 28.5 | 3 | 15.0 | 0.83 | 0.38 | 0.24 | |
| Neurological Disease | 4 | 4.3 | 0 | 0.0 | 4 | 8.1 | 0 | 0.0 | 0.16 | – | 0.19 | |
| Hypertension | 34 | 36.9 | 11 | 47.8 | 16 | 32.6 | 7 | 35.0 | 0.22 | 0.41 | 0.85 | |
| PM | 5 | 5.4 | 3 | 13.0 | 2 | 4.0 | 0 | 0.0 | 0.17 | 0.10 | 0.37 | |
| CA | 19 | 22.6 | 9 | 40.9 | 9 | 21.4 | 1 | 5.0 | 0.10 | < 0.05 | 0.10 | |
| RA | 7 | 7.6 | 2 | 8.6 | 4 | 8.1 | 1 | 5.0 | 0.94 | 0.64 | 0.65 | |
| Cortisone | 6 | 6.5 | 2 | 4.0 | 2 | 4.0 | 2 | 10.0 | 0.43 | 0.89 | 0.35 | |
| ASS | 7 | 7.6 | 1 | 10.2 | 5 | 10.2 | 1 | 5.0 | 0.41 | 0.92 | 0.49 | |
| Coumarin derivative | 8 | 8.6 | 4 | 17.3 | 2 | 4.0 | 2 | 10.0 | 0.06 | 0.50 | 0.35 | |
Abbreviations: BMI body mass index, ASA class American Society of Anesthesiologists, COPD chronic obstructive pulmonary disease, PM pacemaker, CA cardiac arrhythmias, RA rheumatoid arthritis, ASS acetylsalicylic acid, coumarin derivative – phenprocoumon. Statistical analyses regarding p-values were performed between the three columns/groups, i.e. early complications (2), late complications (3) and no complications (4); see superscripted numbers (significance at p < 0.05 or at p < 0.01)
Intraoperative data
| 1 | 2 | 3 | 4 | 5 | 6 | 7 | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total | Early complications | Late complications | No complications |
|
|
| |||||
|
| % |
| % |
| % |
| % | ||||
| Previous Spine operations -Total | 27 | 29.3 | 8 | 34.7 | 15 | 30.6 | 4 | 20.0 | 0.73 | 0.29 | 0.38 |
| Nucelotomies | 8 | 8.6 | 2 | 8.7 | 4 | 8.2 | 2 | 10.0 | 0.94 | 0.89 | 0.81 |
| Spinal canal decompressions | 19 | 20.6 | 6 | 26 | 11 | 22.4 | 2 | 10.0 | 0.74 | 0.18 | 0.24 |
| Fused segments | 5.2 ± 2.2 | 4.8 ± 1.9 | 5.6 ± 2.5 | 4.7 ± 1.6 | 0.16 | 0.89 | 0.14 | ||||
| Dorsoventral approach | 35 | 38 | 8 | 34.7 | 23 | 46.9 | 4 | 20.0 | 0.34 | 0.29 | < 0.05 |
| Pedicle Screw augmentation | 16 | 17.3 | 6 | 26 | 6 | 12.2 | 4 | 20.0 | 0.15 | 0.65 | 0.41 |
| Vertebroplasty | 17 | 18.4 | 6 | 26 | 7 | 14.3 | 4 | 20.0 | 0.23 | 0.65 | 0.56 |
| ALIF | 39 | 42.3 | 7 | 30.4 | 27 | 55.1 | 5 | 25.0 | 0.18 | 0.70 | 0.13 |
| TLIF | 54 | 58.6 | 17 | 73.9 | 26 | 53 | 11 | 55.0 | 0.11 | 0.25 | 0.89 |
| Operation time (min) | 341.1 ± 87.6 | 347.1 ± 102.7 | 361.1 ± 77.9 | 296.9 ± 78.9 | 0.57 | 0.10 | < 0.01 | ||||
| Intraoperative blood loss (ml) | 1567.3 ± 1098.4 | 1884.0 ± 1444.4 | 1602.7 ± 1065.3 | 1178.0 ± 580.3 | 0.39 | 0.05 | 0.10 | ||||
| CATS blood (ml) | 344.9 ± 355.6 | 577.4 ± 522.7 | 353.5 ± 326.7 | 313.2 ± 235.8 | 0.97 | 0.72 | 0.62 | ||||
| Perioperative | |||||||||||
| RBC | 3.3 ± 5.5 | 5.6 ± 7.2 | 3.2 ± 5.3 | 0.9 ± 1.1 | 0.12 | < 0.05 | 0.06 | ||||
| FFP | 2.5 ± 4.7 | 4.4 ± 6.6 | 2.2 ± 4.2 | 1.1 ± 1.5 | 0.10 | < 0.05 | 0.24 | ||||
Abbreviations: ALIF and TLIF anterior and transforaminal lumbar interbody fusion, RBC red blood cell packs, FFP fresh frozen plasma units, CATS-blood continuous autotransfusion system blood. Statistical analyses regarding p-values were performed between the three columns/groups, i.e. early complications (2), late complications (3) and no complications (4); see superscripted numbers (significance at p < 0.05 or at p < 0.01)
Postoperative complications and re-operations
| 1 | 2 | 3 | 4 | 5 | 6 | 7 | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total | Early complications | Late complications (> 30 d) | No complications |
|
|
| |||||
|
| % |
| % |
| % |
| % | ||||
| Wound healing defects | 17 | 18.4 | 12 | 52.1 | 5 | 10.2 | 0 | 0 | < 0.01 | < 0.01 | 0.14 |
| Wound dehiscence, delayed healing | 10 | 10.9 | 6 | 26 | 4 | 8.2 | 0 | 0 | < 0.05 | < 0.05 | 0.18 |
| Superficial infection | 7 | 7.6 | 6 | 26 | 1 | 2.0 | 0 | 0 | < 0.01 | < 0.05 | 0.53 |
| Operation due to wound healing defects | 13 | 14.1 | 11 | 47.8 | 2 | 4.1 | 0 | 0 | < 0.01 | < 0.01 | 0.37 |
| Postoperative Paresis | 13 | 14.1 | 6 | 26 | 7 | 14.3 | 0 | 0 | 0.23 | < 0.05 | 0.08 |
| Epidural hematoma | 6 | 6.5 | 5 | 21.7 | 1 | 2.0 | 0 | 0 | < 0.01 | < 0.05 | 0.53 |
| Re-Operation | 6 | 6.5 | 5 | 21.7 | 1 | 2.0 | 0 | 0 | < 0.01 | < 0.05 | 0.53 |
| Dural leak | 7 | 8.7 | 1 | 5.2 | 6 | 14.6 | 0 | 0 | 0.30 | 0.31 | 0.07 |
| Re-Operation | 1 | 1.2 | 1 | 5.2 | 0 | 0 | 0 | 0 | 0.14 | 0.31 | – |
| Adjacent segment failure Total (n) | 33 | 35.8 | 12 | 52.1 | 21 | 42.9 | 0 | 0 | 0.47 | < 0.01 | < 0.01 |
| Adjacent segment failure during hospital stay | 8 | 8.7 | 8 | 34.8 | 0 | 0 | 0 | 0 | < 0.01 | < 0.01 | – |
| Re-Operation | 8 | 8.7 | 8 | 34.8 | 0 | 0 | 0 | 0 | < 0.01 | < 0.01 | – |
| Adjacent segment failure later on | 25 | 27.2 | 4 | 17.4 | 21 | 42.8 | 0 | 0 | < 0.01 | < 0.01 | < 0.01 |
| After how many months | 9.3 ± 6.3 | 6.7 ± 8.0 | 9.85 ± 6.1 | 0 | 0.19 | < 0.01 | < 0.01 | ||||
| Re-Operation | 22 | 23.9 | 3 | 13.0 | 19 | 38.7 | 0 | 0 | < 0.01 | < 0.05 | < 0.01 |
Statistical analyses regarding p-values were performed between the three columns/groups, i.e. early complications (2), late complications (3) and no complications (4); see superscripted numbers (significance at p < 0.05 or at p < 0.01)
Early adjacent segment failure (ASF) complications requiring surgical treatment are listed below. (Sex: F = female, M = male)
| Case | Sex, Age (years) | Previous operations | Fusion length | ASF | Cause and further treatment |
|---|---|---|---|---|---|
| 1 | M, 62 | Yes | 2 | Yes | Patient had persitant back pain postoperatively and paresthesia in the lower extremity. MRI showed an adjacent vertebral fracture leading to an elongation of the initial fusion of up to 4 segments and second explorative operation due to persistant paresthesia. No specific cause was identifed for this. Sensation returned to normal in the further course. |
| 2 | F, 67 | No | 6 | Yes | Early adjacent failure was caused by an osteoporotic cut out of the upper uncemented pedicle screws. This led to an elongation of the fusion by two segements with cement-augmentation. |
| 3 | F, 74 | No | 5 | Yes | After the inital dorsoventral fusion, an osteoporotic adjacent segment failure in the upper instrumented vertebra caused the need of a fusion extension of one more segment with pedicle screw cement augmention. Thereafter, the patient developed a wound dehiscence. This led to a further operation for wound debridement and closure. |
| 4 | M, 65 | No | 6 | Yes | This adjacent segment failure included a pedicle fracture causing a transient paresis of the hip flexion requiring immediate screw removal and nerve exploration. There was no nerve root damage. The fusion was elongated by 2 levels. The muscle regained full function in the follow-ups. |
| 5 | F, 72 | No | 4 | Yes | This patient had a screw misplacement as idenfied by the CT-scan. The screw was causing irritation of the nerve root and had a cut out through upper vertebral plate. This complex cause of adjacent segment failure and spinal nerve compression lead to an early revision and elongation by one segment. |
| 6 | M, 85 | No | 5 | Yes | This patient showed during the primary operation a poor bone quality (osteoporosis) with the need to use cement augmentation of the upper instrumented vertebra. During the early mobilisation process, the patient suffered an adjacent vertebral fracture with progression needing a revision with elongation of 2 more segments with careful cement augmentation. |
| 7 | F, 67 | No | 6 | Yes | Due to osteoporotic bone, the upper pedicle screws were cement augmented. However, the poor bone quality caused an osteoporotic fracture with nerve irritation needing a revision surgery with elongation of the fusion by 2 segments. Unfortunately thereafter, a wound healing defect caused a further superfical wound revision. |
| 8 | F, 83 | No | 3 | Yes | Due to a collapse of the upper vertebral plate during the mobilisation process, a surgical revision with elongation of 1 segment with cement augmentation was necessary. |
Postoperative complications with conservative treatment, in-hospital stay and follow-up times
| 1 | 2 | 3 | 4 | 5 | 6 | 7 | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total | Early complications (< 30 d) | Late complications | No complications |
|
|
| |||||
|
| % |
| % |
| % |
| % | ||||
| Electrolyte disturbances | 9 | 9.8 | 2 | 0.09 | 7 | 0.14 | 0 | 0.00 | 0.51 | 0.19 | 0.08 |
| UTI | 8 | 8.7 | 3 | 0.15 | 5 | 0.13 | 0 | 0.00 | 0.79 | 0.07 | 0.10 |
| Sciatic pain | 22 | 23.9 | 12 | 0.52 | 10 | 0.20 | 0 | 0.00 | < 0.05 | < 0.01 | < 0.05 |
| Hypoesthesia | 3 | 3.3 | 1 | 0.04 | 2 | 0.04 | 0 | 0.00 | 0.96 | 0.36 | 0.37 |
| Intensive pain-therapy | 14 | 15.2 | 5 | 0.22 | 9 | 0.18 | 0 | 0.00 | 0.74 | < 0.05 | < 0.05 |
| Thrombosis | 0 | 0.0 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | – | – | – |
| Pulmonary embolism | 0 | 0.0 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | – | – | – |
| Stroke | 0 | 0.0 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | – | – | – |
| Death | 2 | 2.2 | 1 | 0.04 | 1 | 0.02 | 0 | 0.00 | 0.58 | 0.36 | 0.53 |
| Hospital Stay (d) | 21.9 ± 10.0 | 31.6 ± 12.6 | 20.1 ± 6.8 | 15.0 ± 3.2 | < 0.01 | < 0.01 | < 0.01 | ||||
| Follow-up time (months) | 16.4 ± 13.8 | 14.1 ± 10.9 | 17.6 ± 15.2 | 15.8 ± 13.8 | 0.32 | 0.67 | 0.63 | ||||
Abbreviations: UTI urinary tract infection. Duration of in-hospital stay is registered in days (d) and clinical follow-up visits are documented in months. Statistical analyses regarding p-values were performed between the three columns/groups, i.e. early complications (2), late complications (3) and no complications (4); see superscripted numbers (significance at p < 0.05 or at p < 0.01)